These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2653415)

  • 21. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Bender Atik R; Bloemenkamp KW; Brady R; Briley AL; Cavallaro R; Cheong YC; Chu JJ; Eapen A; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Ross JA; Sharpe L; Stewart J; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    N Engl J Med; 2015 Nov; 373(22):2141-8. PubMed ID: 26605928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials.
    Soliman S; Daya S; Collins J; Hughes EG
    Fertil Steril; 1994 Jun; 61(6):1068-76. PubMed ID: 8194619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestagen therapy for recurrent miscarriage.
    Szekeres-Bartho J; Balasch J
    Hum Reprod Update; 2008; 14(1):27-35. PubMed ID: 18037606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sporadic pregnancy loss and recurrent miscarriage.
    Devall AJ; Coomarasamy A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():30-39. PubMed ID: 32978069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: A meta-analysis of randomized controlled studies.
    Lin T; Chen Y; Cheng X; Li N; Sheng X
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():53-57. PubMed ID: 30660037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practical approach to the prevention of miscarriage: Part 1--Progesterone therapy.
    Check JH
    Clin Exp Obstet Gynecol; 2009; 36(4):203-8. PubMed ID: 20101845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fundamental role of folliculo-luteal function in recurrent miscarriage.
    Siklósi GS; Bánhidy FG; Ács N
    Arch Gynecol Obstet; 2012 Nov; 286(5):1299-305. PubMed ID: 22744848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin supplementation for preventing miscarriage.
    Rumbold A; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004073. PubMed ID: 15846697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies?
    Ogasawara M; Kajiura S; Katano K; Aoyama T; Aoki K
    Fertil Steril; 1997 Nov; 68(5):806-9. PubMed ID: 9389806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
    Am J Reprod Immunol; 1994 Sep; 32(2):55-72. PubMed ID: 7826502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
    Tempfer CB; Kurz C; Bentz EK; Unfried G; Walch K; Czizek U; Huber JC
    Fertil Steril; 2006 Jul; 86(1):145-8. PubMed ID: 16716321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study.
    Ku CW; Allen JC; Lek SM; Chia ML; Tan NS; Tan TC
    BMC Pregnancy Childbirth; 2018 Sep; 18(1):360. PubMed ID: 30185145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials.
    Barbosa MW; Silva LR; Navarro PA; Ferriani RA; Nastri CO; Martins WP
    Ultrasound Obstet Gynecol; 2016 Aug; 48(2):161-70. PubMed ID: 26577241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone supplements do not reduce risk of recurrent miscarriage, study shows.
    Mayor S
    BMJ; 2015 Nov; 351():h6359. PubMed ID: 26610364
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials.
    Hirahara F; Andoh N; Sawai K; Hirabuki T; Uemura T; Minaguchi H
    Fertil Steril; 1998 Aug; 70(2):246-52. PubMed ID: 9696215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luteal phase HCG support for unexplained recurrent pregnancy loss - a low hanging fruit?
    Fox C; Azores-Gococo D; Swart L; Holoch K; Savaris RF; Likes CE; Miller PB; Forstein DA; Lessey BA
    Reprod Biomed Online; 2017 Mar; 34(3):319-324. PubMed ID: 28041830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.